Leptin therapy in people with congenital leptin deficiency

Gilberto Paz-Filho, Julio Licinio

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Leptin is an adipokine synthesized mainly by the white adipose tissue, with a key role in the regulation of food intake and energy balance. In humans, leptin deficiency is observed in cases of lipodystrophy, functional hypothalamic amenorrhea, and congenital leptin deficiency (CLD) due to mutations in the leptin gene. To date, 34 cases of CLD have been described in the literature, with eight different mutations in the leptin gene been identified so far. For these patients, leptin replacement therapy with metreleptin (a recombinant leptin analog) is the only available therapy, which has been offered to most of these patients. The analysis of the effects of leptin replacement therapy in patients with CLD has shown that leptin has diverse effects, not only by leading to substantial weight loss due to decreases in food intake, but also to endocrine, metabolic, immune, and both structural and functional changes in the brain. A better understanding of the physiological roles of leptin may lead to the development of leptin-based therapies for more prevalent disorders such as fatty liver disease and neurocognitive diseases.

LanguageEnglish
Title of host publicationLeptin
Subtitle of host publicationRegulation and Clinical Applications
PublisherSpringer International Publishing
Pages203-214
Number of pages12
ISBN (Electronic)9783319099156
ISBN (Print)9783319099149
DOIs
Publication statusPublished - 1 Jan 2015

Keywords

  • Congenital leptin deficiency
  • Leptin
  • Metreleptin
  • Myalept
  • Obesity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Paz-Filho, G., & Licinio, J. (2015). Leptin therapy in people with congenital leptin deficiency. In Leptin: Regulation and Clinical Applications (pp. 203-214). Springer International Publishing. https://doi.org/10.1007/978-3-319-09915-6_16
Paz-Filho, Gilberto ; Licinio, Julio. / Leptin therapy in people with congenital leptin deficiency. Leptin: Regulation and Clinical Applications. Springer International Publishing, 2015. pp. 203-214
@inbook{c63cf4cc8607451eb034f878459f2559,
title = "Leptin therapy in people with congenital leptin deficiency",
abstract = "Leptin is an adipokine synthesized mainly by the white adipose tissue, with a key role in the regulation of food intake and energy balance. In humans, leptin deficiency is observed in cases of lipodystrophy, functional hypothalamic amenorrhea, and congenital leptin deficiency (CLD) due to mutations in the leptin gene. To date, 34 cases of CLD have been described in the literature, with eight different mutations in the leptin gene been identified so far. For these patients, leptin replacement therapy with metreleptin (a recombinant leptin analog) is the only available therapy, which has been offered to most of these patients. The analysis of the effects of leptin replacement therapy in patients with CLD has shown that leptin has diverse effects, not only by leading to substantial weight loss due to decreases in food intake, but also to endocrine, metabolic, immune, and both structural and functional changes in the brain. A better understanding of the physiological roles of leptin may lead to the development of leptin-based therapies for more prevalent disorders such as fatty liver disease and neurocognitive diseases.",
keywords = "Congenital leptin deficiency, Leptin, Metreleptin, Myalept, Obesity",
author = "Gilberto Paz-Filho and Julio Licinio",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-09915-6_16",
language = "English",
isbn = "9783319099149",
pages = "203--214",
booktitle = "Leptin",
publisher = "Springer International Publishing",

}

Paz-Filho, G & Licinio, J 2015, Leptin therapy in people with congenital leptin deficiency. in Leptin: Regulation and Clinical Applications. Springer International Publishing, pp. 203-214. https://doi.org/10.1007/978-3-319-09915-6_16

Leptin therapy in people with congenital leptin deficiency. / Paz-Filho, Gilberto; Licinio, Julio.

Leptin: Regulation and Clinical Applications. Springer International Publishing, 2015. p. 203-214.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Leptin therapy in people with congenital leptin deficiency

AU - Paz-Filho, Gilberto

AU - Licinio, Julio

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Leptin is an adipokine synthesized mainly by the white adipose tissue, with a key role in the regulation of food intake and energy balance. In humans, leptin deficiency is observed in cases of lipodystrophy, functional hypothalamic amenorrhea, and congenital leptin deficiency (CLD) due to mutations in the leptin gene. To date, 34 cases of CLD have been described in the literature, with eight different mutations in the leptin gene been identified so far. For these patients, leptin replacement therapy with metreleptin (a recombinant leptin analog) is the only available therapy, which has been offered to most of these patients. The analysis of the effects of leptin replacement therapy in patients with CLD has shown that leptin has diverse effects, not only by leading to substantial weight loss due to decreases in food intake, but also to endocrine, metabolic, immune, and both structural and functional changes in the brain. A better understanding of the physiological roles of leptin may lead to the development of leptin-based therapies for more prevalent disorders such as fatty liver disease and neurocognitive diseases.

AB - Leptin is an adipokine synthesized mainly by the white adipose tissue, with a key role in the regulation of food intake and energy balance. In humans, leptin deficiency is observed in cases of lipodystrophy, functional hypothalamic amenorrhea, and congenital leptin deficiency (CLD) due to mutations in the leptin gene. To date, 34 cases of CLD have been described in the literature, with eight different mutations in the leptin gene been identified so far. For these patients, leptin replacement therapy with metreleptin (a recombinant leptin analog) is the only available therapy, which has been offered to most of these patients. The analysis of the effects of leptin replacement therapy in patients with CLD has shown that leptin has diverse effects, not only by leading to substantial weight loss due to decreases in food intake, but also to endocrine, metabolic, immune, and both structural and functional changes in the brain. A better understanding of the physiological roles of leptin may lead to the development of leptin-based therapies for more prevalent disorders such as fatty liver disease and neurocognitive diseases.

KW - Congenital leptin deficiency

KW - Leptin

KW - Metreleptin

KW - Myalept

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84944632856&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-09915-6_16

DO - 10.1007/978-3-319-09915-6_16

M3 - Chapter

SN - 9783319099149

SP - 203

EP - 214

BT - Leptin

PB - Springer International Publishing

ER -

Paz-Filho G, Licinio J. Leptin therapy in people with congenital leptin deficiency. In Leptin: Regulation and Clinical Applications. Springer International Publishing. 2015. p. 203-214 https://doi.org/10.1007/978-3-319-09915-6_16